ARTICLE | Clinical News
Zevalin ibritumomab tiuxetan regulatory update
August 1, 2005 7:00 AM UTC
Centers for Medicare & Medicaid Services (CMS) will not draft a national coverage determination for the radiolabeled antibody Zevalin. Zevalin is marketed for non-Hodgkin's lymphoma (NHL). CMS will ma...